摘要
Multiple drug resistance(MDR)is the tumor’s way of escaping the cytotoxic effects of various unrelated chemotherapeutic drugs.It can be either innate or acquired.MDR represents the end of the therapeutic pathway,and it practically leaves no treatment alternatives.Reversing MDR is an unfulfilled goal,despite the important recent advances in cancer research.MDR,the main cause of death in cancer patients,is a multi-factorial development,and most of its known causes have been thoroughly discussed in the literature.However,there is one aspect that has not received adequate consideration-intracellular alkalosis-which is part of wider pH deregulation where the pH gradient is inverted,meaning that extracellular pH is decreased and intracellular pH increased.This situation interacts with MDR and with the proteins involved,such as P-gp,breast cancer resistance protein,and multidrug associated resistance protein 1.However,there are also situations in which these proteins play no role at all,and where pH takes the lead.This is the case in ion trapping.Reversing the pH gradient to normal can be an important contribution to managing MDR.The drugs to manipulate pH exist,and most of them are FDA approved and in clinical use for other purposes.Furthermore,they have low or no toxicity and are inexpensive compared with any chemotherapeutic treatment.Repurposing these drugs and combining them in a reasonable fashion is one of the points proposed in this paper,which discusses the relationship between cancer’s peculiar pH and MDR.
